期刊文献+

中西医结合治疗中晚期胃癌64例报告 被引量:17

Integrated Traditional Chinese and Western Medicine in the Treatment of Medium and Advanced Gastric Cancer:Report of 64 Cases
暂未订购
导出
摘要 目的观察中西医结合治疗中晚期胃癌的临床疗效。方法收集自2010年4月至2013年4月我院消化科收治的中晚期胃癌患者64例,随机分为实验组与对照组各32例。对照组采用西药单独治疗,实验组在西药治疗的基础上加用健脾益气的中药调理。所有患者随访2年,观察比较两组患者治疗后的临床疗效。结果实验组治疗总有效率为84.38%,显著高于对照组的40.63%,差异具有统计学意义(P<0.05)。实验组治疗后胃癌的临床症状得到明显的缓解,与对照组相比差异有统计学意义(P<0.05)。结论中西医结合治疗中晚期胃癌的临床效果比单独使用西药治疗更好,胃癌的临床症状得到明显改善,且应用中药可明显降低单独使用西药化疗产生的毒副反应,提高了带病患者的生活质量,值得广泛在临床上推广使用。 Objective To observe the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of medium and advanced gastric cancer. Methods 64 patients with medium or advanced gastric cancer admitted in gastroenterology department from April 2010 to April 2013 were randomly divided into two groups, with 32 cases in each group. Patients in the control group received western medicine treatment alone, while patients in the experimental group received Chinese medicine regulation of spleen and replenishing qi on the basis of western medicine treatment. All patients were followed-up for 2 years, and the clinical effects were compared between two groups. Results The total effective rate of experimental group was 84.38% (27/32), siguificantly higher than 40.63% of control group (P〈0.05). The improvement of clinical symptoms of gastric cancer of experimental group was better than that of control group (P〈0.05). Conclusions Integrated traditional Chinese and western medicine has better clinical effect than western medicine treatment alone in the treatment of medium and advanced gastric cancer. It can improve the clinical symptoms of gastric cancer, reduce the toxic and adverse effect, and improve patients' quality of life, which is worthy of clinical promotion.
出处 《临床医学工程》 2014年第4期467-468,共2页 Clinical Medicine & Engineering
关键词 中西医结合 胃癌 临床效果 毒副反应 Integrated traditional Chinese and western medicine Gastric cancer Clinical effect Toxic and adverse effect
  • 相关文献

参考文献12

二级参考文献99

共引文献76

同被引文献126

  • 1王海波,吴式琇,黄庆科.中西医疗效评价方法在进展期胃癌中的比较研究[J].浙江中医药大学学报,2011,35(5):673-675. 被引量:7
  • 2王纯,卢宏达,孔庆志.香菇多糖增强XELOX方案治疗晚期胃癌疗效研究[J].中国生化药物杂志,2014,34(1):95-96. 被引量:8
  • 3樊江丽,李东芳.中晚期胃癌中医药治疗研究进展[J].四川中医,2013,31(8):176-179. 被引量:8
  • 4刘福坤,姚学权.胃癌的新辅助化疗[J].中国普外基础与临床杂志,2006,13(1):17-20. 被引量:25
  • 5王小龙,附舰,安鹏,李伟涛,陈光伟.中西医结合治疗胃癌31例[J].现代中医药,2007,27(3):18-19. 被引量:8
  • 6[3]周际昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2006:266.
  • 7Katsuhiko Higuchi MD,Alexandria Phan MD,Jaffer A. Ajani MD.Gastric cancer: Advances in adjuvant and adjunct therapy[J].Current Treatment Options in Oncology.2003(5)
  • 8Bodoky G,ScheulenM E,Rivera F,et al.Clinical Benefit and Health-Related Quality of Life Assessmentin Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point ResultsFrom the First-Line Advanced Gastric Cancer Study (FLAGS)[J].2015,46(2):109-1017.
  • 9Shi Y,Yu P,Zeng D,et al.Suppression of vascular endothelial growth factor abrogates the immunosuppressive capability of murine gastric cancer cells and elicits antitumor immunity [J].FEBS J,2014,281(17):3882-3893.
  • 10Mao C,Mou X,Zhou Y,et al.Tumor-activated TCRγδD T cellsfrom gastric cancer patients induce the antitumor immune response of TCRαβ□ T cells via their antigen-presenting cell-like effects[J],J Immunol Res,2014,2014:593562.

引证文献17

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部